Muhammad Furqan, MD
Medical Oncology · Oklahoma City, OKNPI 1306090220
Payments from drug & device makers
Across 1,374 payments — averaging $12,021 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$5.5M
- Amgen$4.7M
- AbbVie$1.7M
- Merck$1.7M
- Beigene, Ltd.$938K
- GSK$564K
- plus $1.5M from 16 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 30 | $5,500,517 |
| Amgen | 16 | $4,653,874 |
| AbbVie | 666 | $1,678,993 |
| Merck | 22 | $1,654,656 |
| Beigene, Ltd. | 157 | $938,395 |
| GSK | 244 | $564,260 |
| Genmab U.S., Inc. | 33 | $328,348 |
| Mirati Therapeutics, Inc. | 15 | $287,581 |
| Incyte Corporation | 129 | $218,712 |
| Beone Medicines Ltd. | 1 | $196,203 |
| Pfizer | 10 | $171,576 |
| Novartis | 12 | $73,866 |
| Genentech, Inc. | 6 | $56,644 |
| Eli Lilly | 3 | $55,481 |
| Bristol Myers Squibb | 2 | $46,768 |
| Beone Medicines USA, Inc. | 7 | $38,910 |
| E.r. Squibb & Sons, L.L.C. | 8 | $32,519 |
| F. Hoffmann-la Roche AG | 5 | $12,713 |
| Viiv Healthcare Company | 2 | $5,898 |
| Janssen Scientific Affairs, LLC | 1 | $1,010 |
| Biontech SE | 4 | $204 |
| Genentech USA, Inc. | 1 | $53 |
How this compares
Too few medical oncology providers in Oklahomato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other medical oncology in Oklahoma City
- Mathew CherianOklahoma City$174K
- Aleda TomaOklahoma City$5K
- Meredith LaroseOklahoma City$241
- Sagun ShresthaTulsa$1.2M
- Simeon JaggernauthTulsa$116K
- Tariq MahmoodNorman$13K
- Sumbal NabiEnid$6K
- Jennifer O StasikTulsa$3K
- Manjula KrishnamurthiMuskogee$360
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.